Given the recognized window of opportunity in early PsA, future research should prioritize trials in patients with subclinical joint involvement, arthralgia, or early enthesitis, especially those with coexisting obesity or MetS
At week 72, the percentage change in weight was -15.0% with 5 mg of tirzepatide, -19.5% with 10 mg, and -20.9% with 15 mg, compared to -3.1% with the placebo
[7] The resulting half-life of active GLP-1 is approximately 2 minutes, which is however sufficient to activate GLP-1 receptors
Injections are probably useless if you dont have a deficiency
A doctor may choose injections over oral supplementation to limit any barriers to absorption
Individual difference gene polymorphism (such as MC1 receptor sensitivity) and basic diseases (such as hypertension and diabetes) may affect the type and severity of adverse reactions